Oseltamavir: Difference between revisions
| Line 13: | Line 13: | ||
*9-23 months: 7 mg/kg/day PO divided BID | *9-23 months: 7 mg/kg/day PO divided BID | ||
*2-12 years: | *2-12 years: | ||
**<15kg: 30 mg PO BID | |||
**16-23kg: 45 mg PO BID | |||
**24-40kg: 60 mg PO BID | |||
^^>40kg: 75 mg PO BID | |||
==Special Populations== | ==Special Populations== | ||
Revision as of 19:38, 19 June 2015
General
- Type:
- Dosage Forms:
- Common Trade Names:
Adult Dosing
Influenza
75mg PO BID x5d
Pediatric Dosing
5 day course
- 1-8 months: 6 mg/kg/day PO divided BID
- 9-23 months: 7 mg/kg/day PO divided BID
- 2-12 years:
- <15kg: 30 mg PO BID
- 16-23kg: 45 mg PO BID
- 24-40kg: 60 mg PO BID
^^>40kg: 75 mg PO BID
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Adult
- Pediatric
- Hepatic Dosing
- Adult
- Pediatric
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: